Back to Business

Astellas begins phase 3 trial of ASP2138 for gastric cancer

Business August 24, 2026 at 11:36 PM

Astellas begins phase 3 trial of ASP2138 for gastric cancer

Investing.com

Read at Investing.com

More Stories

G8 Education H1 2026 slides: occupancy drop hits earnings

G8 Education H1 2026 slides: occupancy drop hits earnings

🇺🇸 Investing.com 22m ago

Earnings call transcript: Tyro Payments posts stronger FY 2026 cash flow, shares edge up

Earnings call transcript: Tyro Payments posts stronger FY 2026 cash flow, shares edge up

🇺🇸 Investing.com 23m ago

Earnings call transcript: Scentre Group lifts H1 2026 guidance on strong growth

Earnings call transcript: Scentre Group lifts H1 2026 guidance on strong growth

🇺🇸 Investing.com 23m ago

Your world briefing, in your pocket

AI-curated news from 12 countries and 10 languages — coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play